Securities code: Hvsen Biotechnology Co.Ltd(300871) securities abbreviation: Hvsen Biotechnology Co.Ltd(300871) Announcement No.: 2022026 convertible bond Code: 123132 convertible bond abbreviation: Huisheng convertible bond
Hvsen Biotechnology Co.Ltd(300871)
Announcement on holding 2021 online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hvsen Biotechnology Co.Ltd(300871) (hereinafter referred to as "the company") has disclosed the full text of the 2021 annual report and the summary of the 2021 annual report on cninfo.com on March 11, 2022. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's business performance and development strategy, the company is scheduled to be on "value online" from 15:30 to 17:00 on Tuesday, March 15, 2022（ https://www.ir-online.com.cn./ ）Hold the 2021 online performance briefing, communicate and exchange with investors, and widely listen to the opinions and suggestions of investors.
1、 Explain the time, place and mode of the meeting
Meeting time: 15:30-17:00, Tuesday, March 15, 2022
Meeting mode: network interaction mode
Venue: Value Online（ https://www.ir-online.com.cn./ ）
2、 Participants
Mr. Zhang Weiyuan, chairman and general manager, Mr. Xie Huobao, independent director, Mr. Liu Jie, deputy general manager, Mr. Yang Kaijie, deputy general manager, Secretary of the board of directors and chief financial officer, and Mr. Chen Yuan, sponsor representative.
3、 Investor participation mode
Investors can visit the website from 15:30-17:00 on Tuesday, March 15, 2022 https://eseb.cn./T9ZULKvGEw Or use wechat to scan the following small program codes to participate in interactive communication. Investors can visit before March 15, 2022, open interactive exchanges and ask questions before the meeting. The company will answer the questions generally concerned by investors within the scope of information disclosure through this performance briefing.
It is hereby announced.
Hvsen Biotechnology Co.Ltd(300871) board of directors March 11, 2022
